SHREVEPORT, La. - A new landmark study published in The Lancet is changing how doctors treat certain head and neck cancers.

For patients with stage III or IV oropharyngeal cancer, intensity-modulated proton therapy (IMPT) is noninferior to i ...

Proton radiotherapy (RT) for oropharyngeal cancer matched conventional photon therapy for slowing disease progression and led ...

A new study published today in The Lancet showed a significant survival benefit for patients with oropharyngeal cancers who were treated with proton therapy (IMPT) compared to those treated with ...

Photon therapy offers strong outcomes in treating oropharyngeal cancers; however, some radiation can reach and damage nearby healthy tissue. The damage can lead to side effects that may be severe for ...

These results establish proton therapy as a transforming, safe, and patient-focused solution, poised to redefine the global standard of care for oropharyngeal cancer.

Ben’s Cup youth hockey tournament returned to Edmonton for a second consecutive year to raise funds to help create Canada’s ...

USA: A large US-based phase III clinical trial has shown that proton radiotherapy offers a meaningful survival advantage and ...

New research found patients with certain head and neck cancers lived longer and experienced fewer side effects when treated ...

In alignment with the national framework for the advancement of proton therapy, facilitated by the National Cancer Center, ...

A new center offering treatment for cancer patients is expected to make its debut in the spring.

Stephen McMahon has received funding from the European Commission. High energy proton beam therapy, an advanced form of radiotherapy, made its debut in the UK in 2018. Both the NHS and private clinics ...